As of July 31st, Chugai Pharma Taiwan Ltd. and Chugai Pharma R&D Taiwan Ltd. merged with the aim to maximize the value of Chugai’s development products by establishing seamless operations from development to commercialization.
Mission of new Chugai Pharma Taiwan is to add exceptional value through the activities of development, commercialization, and services for the benefit of the medical community and human health in Taiwan and extended to the world. We undertake actions that give the highest priority to patients and consumers.
Oncology, cardiovascular diseases, and bone and joint diseases are positioned as Chugai Pharma Taiwan's strategic areas where we accelerate introduction of new products into Taiwan market.
We are dedicated to succeed as a pharmaceutical industry leader. Our mission as a member of Chugai Group is to deliver exceptional value to stakeholders including patients, their families, and medical professionals through the creation of innovative medical products and services. We will constantly embrace challenges in order to fulfill our mission, with all our activities firmly based on a strong ethical foundation as a company engaged in businesses related to the lives of human beings.
We appreciate your understanding and continuous supports on our efforts and activities.